Literature DB >> 17062502

Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window.

Vittorio Colletti1, Sigfrid D Soli, Marco Carner, L Colletti.   

Abstract

Early clinical findings are reported for subjects implanted with the Vibrant Med-El Soundbridge (VSB) device. The present criteria for the VSB, limiting its application to patients with normal middle ear function, have been extended to include patients with ossicular chain defects. Seven patients with severe mixed hearing loss were implanted with the transducer placed onto the round window. All had undergone previous surgery: six had multiple ossiculoplasties, and one had the VSB crimped on the incus with unsuccessful results. Round window implantation bypasses the normal conductive path and provides amplified input to the cochlea. Post-operative aided thresholds of 30 dB HL were achieved for most subjects, as compared with unaided thresholds ranging from 60-80 dB HL. Aided speech reception thresholds at 50% intelligibility were 50 dB HL, with most subjects reaching 100% intelligibility at conversational levels, while unaided thresholds averaged 80 dB HL, with only one subject reaching 100% intelligibility. These results suggest that round window implantation may offer a viable treatment option for individuals with severe mixed hearing losses who have undergone unsuccessful ossiculoplasties.

Entities:  

Mesh:

Year:  2006        PMID: 17062502     DOI: 10.1080/14992020600840903

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  78 in total

Review 1.  [Device-based treatment of mixed hearing loss: An audiological comparison of current hearing systems].

Authors:  T Rahne; S K Plontke
Journal:  HNO       Date:  2016-02       Impact factor: 1.284

2.  [Active middle ear implants: more than "just" a hearing aid].

Authors:  M Praetorius
Journal:  HNO       Date:  2007-09       Impact factor: 1.284

Review 3.  [Semi-implantable hearing aids for sensorineural hearing loss and combined hearing loss: experiences at the German Armed Forces Hospital in Ulm].

Authors:  M Tisch; H Maier
Journal:  HNO       Date:  2009-03       Impact factor: 1.284

4.  [Hearing rehabilitation by means of implantable hearing devices].

Authors:  M Tisch
Journal:  HNO       Date:  2009-03       Impact factor: 1.284

5.  Round window membrane implantation with an active middle ear implant: a study of the effects on the performance of round window exposure and transducer tip diameter in human cadaveric temporal bones.

Authors:  Stéphane Tringali; Kanthaiah Koka; Arnaud Deveze; N Julian Holland; Herman A Jenkins; Daniel J Tollin
Journal:  Audiol Neurootol       Date:  2010-02-11       Impact factor: 1.854

6.  The inferior cochlear vein: surgical aspects in cochlear implantation.

Authors:  Rui Guo; HongLei Zhang; Wei Chen; XiaoQuan Zhu; Wei Liu; Helge Rask-Andersen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-21       Impact factor: 2.503

7.  Complications after round window vibroplasty.

Authors:  Maurizio Barbara; Luigi Volpini; Edoardo Covelli; Martina Romeo; Chiara Filippi; Simonetta Monini
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-27       Impact factor: 2.503

8.  Transtympanic Hearing Aid: exploratory study on a new device.

Authors:  S Berrettini; L Bruschini; A DE Vito; T Gnocco; N C Rosica; L Pizzoli; F Forli
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

9.  The positional relationship between facial nerve and round window niche in patients with congenital aural atresia and stenosis.

Authors:  Keguang Chen; Huiying Lyu; Youzhou Xie; Lin Yang; Tianyu Zhang; Peidong Dai
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-12       Impact factor: 2.503

10.  Vibrant Soundbridge® in preschool children with unilateral aural atresia: acceptance and benefit.

Authors:  M Leinung; E Zaretsky; B P Lange; V Hoffmann; T Stöver; C Hey
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.